Inhalon Biopharma Inc is a startup based in the United States.
Inhalon Biopharma Inc is a startup based in the United States.
Inhalon Biopharma Inc is a clinical-stage biotechnology company developing inhaled monoclonal antibody treatments for acute respiratory infections such as RSV, influenza, and SARS-CoV-2 to enable a simplified test-to-treat care model.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.